Financier Icahn Blasts Mylan-King Merger: ; Ceo: Newest - and Largest - Stockholder 'has an Agenda' for Personal Profit, Not to Help Firm
Charleston Gazette › November 03, 2004
Linked as:
Summary
balow@wvgazette.com
Financier Carl Icahn, who owns nearly 10 percent of Mylan Laboratories Inc. stock, has called the proposed merger of Mylan with King Pharmaceuticals "extremely risky" and urged Mylan officials to avoid the merger "at any price."See the full content of this document
Extract
Financier Icahn Blasts Mylan-King Merger: ; Ceo: Newest - and Largest - Stockholder 'has an Agenda' for Personal Profit, Not to Help Firm
Mylan CEO Robert J. Coury responded Monday to Icahn's letter to Coury, dated Oct. 29, saying, "Mr. Icahn's letter is fill...
See the full content of this document
Sponsored links
